Biologicals targeting type 2 immunity: Lessons learned from asthma, chronic urticaria and atopic dermatitis-Reference-Cited by-同舟云学术

Biologicals targeting type 2 immunity: Lessons learned from asthma, chronic urticaria and atopic dermatitis

Published:2019-08-12 Issue:9 Volume:49 Page:1334-1343
ISSN:0014-2980
Container-title:European Journal of Immunology
language:en
Short-container-title:Eur. J. Immunol.

Author:

Cosmi Lorenzo¹²^ORCID,Maggi Laura¹,Mazzoni Alessio¹,Liotta Francesco¹²,Annunziato Francesco¹^ORCID

Affiliation:

1. Department of Experimental and Clinical Medicine and DENOTHE CenterUniversity of Florence Florence Italy

2. Immunology and Cell Therapy UnitAzienda Ospedaliero‐Universitaria Careggi Florence Italy

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.201948156

Reference59 articles.

1. Asthma: personalized and precision medicine

2. The Next Generation of Immunotherapy for Cancer: Small Molecules Could Make Big Waves

3. T helper cells plasticity in inflammation

4. IL‐4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones;Parronchi P.;J. Immunol.,1992

5. The 3 major types of innate and adaptive cell-mediated effector immunity

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relation of T Cell Profile with Vitamin D Receptor and Vitamin D-Binding Protein Gene Polymorphisms in Atopy;International Journal of Molecular Sciences;2024-08-20

2. Serum Concentration of IL-5 Receptor (IL-5R) and Associations with Disease Severity in Patients with Chronic Spontaneous Urticaria (CSU) and Atopic Dermatitis (AD);International Journal of Molecular Sciences;2024-07-11

3. Immunopathogenesis of urticaria: a clinical perspective on histamine and cytokine involvement;Inflammation Research;2024-03-31

4. Clinical trials of antibody drugs in the treatments of atopic dermatitis;Frontiers in Medicine;2023-09-04

5. Parnassin, a Novel Therapeutic Peptide, Alleviates Skin Lesions in a DNCB-Induced Atopic Dermatitis Mouse Model;Biomedicines;2023-05-08